Replies to post #143564 on NanoViricides Inc. (NNVC)

[KMBJN]

mRNA vaccine is plug and play once you decide on which antigen you want for vaccine. Just create the new mRNA sequence and it goes into the platform tech. First drug of platform is toughest to get started then others much easier. NNVC hopefully will go much quicker on second and third drug if using same nanomicelle backbone .. Just design and synthesize new ligand and attachment method and have a new drug.

Agree though NNVC with never getting into trials yet is very bad. Probably due to manufacturing or CMC issues? Looks like they are close to IND though for real this time, definitely maybe perhaps will see.

[Its_lose_not_loose]

Give credit where credit is due.

Look how many "news" organizations have been paid to "report" NNVC's progress on "collaborations" with respectable organizations.

And how many times they've self-reported that they are able to make kilogram batches of Dr. Diwan's Miracle Elixir, which has the ability to conquer any known virus in the known universe within a matter of weeks (efficacy of which has been proven countless times in their own cGMP facility).

And how many bonuses they've received over the years for NOT advancing anything past IND.

If these things aren't "something" then I don't know what is.

But still it seems like they could have come up with something in the many many years they have completely failed to do so.